A Study to Assess the Effects of Brolucizumab in Adult Patients With Neovascular Age Related Macular Degeneration
Condition(s):Neovascular Age Related Macular DegenerationLast Updated:February 24, 2023Completed
Hide Studies Not Open or Pending
Condition(s):Neovascular Age Related Macular DegenerationLast Updated:February 24, 2023Completed
Condition(s):Age-Related Macular DegenerationLast Updated:August 18, 2022Recruiting
Condition(s):Neovascular Age-Related Macular DegenerationLast Updated:July 10, 2023Completed
Condition(s):Age-related Macular Degeneration (AMD)Last Updated:September 23, 2021Withdrawn
Condition(s):Macula Lutea DegenerationLast Updated:May 12, 2021Unknown status
Condition(s):Degenerative Disc DiseaseLast Updated:January 18, 2020Terminated
Condition(s):Degenerative Disc DiseaseLast Updated:March 15, 2024Completed
Condition(s):AMD; Age-Related Macular DegenerationLast Updated:July 28, 2023Recruiting
Condition(s):Cervical Disc DegenerationLast Updated:November 2, 2022Recruiting
Condition(s):Age-Related Macular DegenerationLast Updated:August 3, 2010Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.